These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7174517)

  • 1. Studies on a new immunoactive peptide, FK-156. IV. Synthesis of FK-156 and its geometric isomer.
    Hemmi K; Aratani M; Takeno H; Okada S; Miyazaki Y; Nakaguchi O; Kitaura Y; Hashimoto M
    J Antibiot (Tokyo); 1982 Oct; 35(10):1300-11. PubMed ID: 7174517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on structure-activity relationships of FK-156, an immunostimulating peptide, and related compounds. II. Synthesis of N2-(gamma-D-glutamyl)-2(L), 2'(D)-diaminopimelic acid as the minimal essential structure of FK-156.
    Takeno H; Okada S; Yonishi S; Hemmi K; Nakaguchi O; Kitaura Y; Hashimoto M
    Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):2932-41. PubMed ID: 6518579
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis and adjuvant activity of FK-156 analogues: acyl derivatives of N-[N2-(L-alanyl-gamma-D-glutamyl)-2(L),2'(D)-diamino-1-pimeloyl ]glycine.
    Okada S; Takeno H; Hemmi K; Kitaura Y; Hashimoto M
    Chem Pharm Bull (Tokyo); 1985 Feb; 33(2):889-92. PubMed ID: 4017131
    [No Abstract]   [Full Text] [Related]  

  • 4. N2-(gamma-D-Glutamyl)-meso-2(L),2'(D)-diaminopimelic acid as the minimal prerequisite structure of FK-156: its acyl derivatives with potent immunostimulating activity.
    Kitaura Y; Nakaguchi O; Takeno H; Okada S; Yonishi S; Hemmi K; Mori J; Senoh H; Mine Y; Hashimoto M
    J Med Chem; 1982 Apr; 25(4):335-7. PubMed ID: 7069711
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on a new immunoactive peptide, FK-156. III. Structure elucidation.
    Kawai Y; Nakahara K; Gotoh T; Uchida I; Tanaka H; Imanaka H
    J Antibiot (Tokyo); 1982 Oct; 35(10):1293-9. PubMed ID: 7174516
    [No Abstract]   [Full Text] [Related]  

  • 6. New convenient synthesis of immunostimulating peptides containing meso-diaminopimelic acid. Syntheses of FK-565 and FK-156.
    Kolodziejczyk AM; Kolodziejczyk AS; Stoev S
    Int J Pept Protein Res; 1992 Apr; 39(4):382-7. PubMed ID: 1428528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on structure-activity relationships of FK-156, an immunostimulating peptide, and related compounds. I. Synthesis of stereoisomeric analogues of FK-156.
    Takeno H; Okada S; Hemmi K; Aratani M; Kitaura Y; Hashimoto M
    Chem Pharm Bull (Tokyo); 1984 Aug; 32(8):2925-31. PubMed ID: 6518578
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on a new immunoactive peptide, FK-156. II. Fermentation, extraction and chemical and biological characterization.
    Gotoh T; Nakahara K; Nishiura T; Hashimoto M; Kino T; Kuroda Y; Okuhara M; Kohsaka M; Aoki H; Imanaka H
    J Antibiot (Tokyo); 1982 Oct; 35(10):1286-92. PubMed ID: 6757224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoactive peptides, FK-156 and FK-565. I. Enhancement of host resistance to microbial infection in mice.
    Mine Y; Yokota Y; Wakai Y; Fukada S; Nishida M; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1983 Aug; 36(8):1045-50. PubMed ID: 6415029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. General stereoselective synthesis of chemically differentiated alpha-diamino acids: synthesis of 2,6-diaminopimelic and 2,7-diaminosuberic acids.
    Hernández N; Martín VS
    J Org Chem; 2001 Jul; 66(14):4934-8. PubMed ID: 11442429
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on a new immunoactive peptide, FK-156. I. Taxonomy of the producing strains.
    Gotoh T; Nakahara K; Iwami M; Aoki H; Imanaka H
    J Antibiot (Tokyo); 1982 Oct; 35(10):1280-5. PubMed ID: 7174515
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunoactive peptides, FK 156 and FK 565. IV. Activation of mouse macrophages.
    Watanabe Y; Tawara S; Mine Y; Kikuchi H
    J Antibiot (Tokyo); 1985 Dec; 38(12):1781-7. PubMed ID: 3005214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoactive peptides, FK-156 and FK-565. III. Enhancement of host defense mechanisms against infection.
    Mine Y; Watanabe Y; Tawara S; Yokota Y; Nishida M; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1983 Aug; 36(8):1059-66. PubMed ID: 6630057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogenic potentials of bestatin, amastatin, arphamenines A and B, FK-156 and FK-565 on spleen lymphocytes.
    Weissmann N; Leyhausen G; Maidhof A; Tanaka W; Umezawa H; Müller WE
    J Antibiot (Tokyo); 1985 Jun; 38(6):772-8. PubMed ID: 4019321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoactive peptides, FK-156 and FK-565. II. Restoration of host resistance to microbial infection in immunosuppressed mice.
    Yokota Y; Mine Y; Wakai Y; Watanabe Y; Nishida M; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1983 Aug; 36(8):1051-8. PubMed ID: 6415030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effects of novel immunoactive peptides, FK-156 and its synthetic derivatives.
    Izumi S; Nakahara K; Gotoh T; Hashimoto S; Kino T; Okuhara M; Aoki H; Imanaka H
    J Antibiot (Tokyo); 1983 May; 36(5):566-74. PubMed ID: 6192122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and RES-stimulating activity of bacterial cell-wall peptidoglycan peptides related to FK-156.
    Kitaura Y; Takeno H; Aratani M; Okada S; Yonishi S; Hemmi K; Nakaguchi O; Hashimoto M
    Experientia; 1982 Sep; 38(9):1101-3. PubMed ID: 7128758
    [No Abstract]   [Full Text] [Related]  

  • 18. (Acyloxy)alkoxy moiety as amino acids protecting group for the synthesis of (R,R)-2,7 diaminosuberic acid via RCM.
    Mollica A; Feliciani F; Stefanucci A; Fadeev EA; Pinnen F
    Protein Pept Lett; 2012 Dec; 19(12):1245-9. PubMed ID: 22670664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Low-molecular weight immunomodulators of microbial origin].
    Khurnova LM; Ivanitskaia LP
    Antibiot Khimioter; 1989 Oct; 34(10):786-92. PubMed ID: 2694992
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of Escherichia coli growth and diaminopimelic acid epimerase by 3-chlorodiaminopimelic acid.
    Baumann RJ; Bohme EH; Wiseman JS; Vaal M; Nichols JS
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1119-23. PubMed ID: 3056252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.